A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID 19 in Hospitalized Adults
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: coronavirus | COVID19 | COVID-19 | COVID 19
Age: Between 18 - 90 Years
Gender: Male or Female
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required